NCT05170334 2025-10-01
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
Clinical Trials
8 trialsNCT04417530 2025-03-03
Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
Aura Biosciences
Phase 2 Completed
NCT00020475 2024-03-04
Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
National Cancer Institute (NCI)
Phase 2 Completed
NCT00254397 2019-10-16
Melanoma Vaccine With Peptides and Leuprolide
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01393769 2016-08-02
Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage
Hospital Sant Joan de Deu
Phase 2 Terminated
NCT00432445 2015-02-27
Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00062933 2012-08-20
A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01151748 2012-05-14
Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma
Stanford University
Phase 2 Withdrawn